Article
Functional T cells trapped behind a stromal wall: a Brake-with-Wall phenotype redefines pancreatic adenocarcinoma immunotherapy resistance
2026-05-14
Abstract excerpt
<h4>Background</h4> Pancreatic ductal adenocarcinoma (PDAC) is the paradigmatic immunotherapy-refractory cancer, with a 5-year survival of approximately 12% and minimal benefit from immune checkpoint blockade (ICB). The dominant mechanistic explanation classifies PDAC as a T cell-excluded “cold” tumor, implying that no functional anti-tumor T cells are available for checkpoint release. Whether this Block-strategy...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b0853b2a-9274-5946-9ee5-f933be52a74f
- DOI
- 10.64898/2026.05.11.724216
